Cross talk between gut microbiota and intestinal mucosal immunity in the development of ulcerative colitis

J Zou, C Liu, S Jiang, D Qian, J Duan - Infection and Immunity, 2021 - Am Soc Microbiol
Ulcerative colitis (UC), a nonspecific inflammatory disease, is characterized by inflammation
and mucosal damage in the colon, and its prevalence in the world is increasing …

Incidence, prevalence, and clinical epidemiology of inflammatory bowel disease in the Arab world: A systematic review and meta-analysis

M Mosli, S Alawadhi, F Hasan… - Inflammatory Intestinal …, 2021 - karger.com
Objectives: Despite the recent findings of the rising incidence of inflammatory bowel disease
(IBD) in Arab countries, there are limited data on the characteristics of IBD patients and the …

[HTML][HTML] Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches

D Alshehri, O Saadah, M Mosli, S Edris… - Bosnian journal of …, 2021 - ncbi.nlm.nih.gov
There is a growing body of evidence reinforcing the unique connections between the host
microbiome, health, and diseases. Due to the extreme importance of the symbiotic …

Quercetin serves as the major component of Xiang-lian Pill to ameliorate ulcerative colitis via tipping the balance of STAT1/PPARγ and dictating the alternative …

H Zhou, C Yang, J Li, Y He, Y Huang, R Qin… - Journal of …, 2023 - Elsevier
Abstract Ethnopharmacological relevance The traditional Chinese herbal formula, Xiang-
lian Pill (XLP), is commonly prescribed for ulcerative colitis (UC) patients to relieve their …

Preventive effect of Atractylodis Rhizoma extract on DSS-induced acute ulcerative colitis through the regulation of the MAPK/NF-κB signals in vivo and in vitro

X Lin, X Guo, L Qu, J Tu, S Li, G Cao, Y Liu - Journal of Ethnopharmacology, 2022 - Elsevier
Abstract Ethnopharmacological relevance Atractylodes lancea (Thunb.) DC. is traditionally
used as a folk medicine for treating gastrointestinal diseases in China. Nevertheless, the …

Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis

RK Mishra, A Ahmad, A Kumar, A Vyawahare… - Materials Science and …, 2020 - Elsevier
Ulcerative colitis is a chronic mucosal inflammatory condition that adversely affects colon
and rectum. Celecoxib is a selective inhibitor of inducible cyclooxygenase-2 (COX-2) and is …

Berberine-loaded nanostructured lipid carriers enhance the treatment of ulcerative colitis

J Deng, Z Wu, Z Zhao, C Wu, M Yuan, Z Su… - International journal …, 2020 - Taylor & Francis
Purpose Berberine (BBR), a major ingredient extracted from Coptis chinensis, is a natural
drug with limited oral bioavailability. We developed nanostructured lipid carriers (NLCs) as a …

Modified Gegen Qinlian decoction ameliorated ulcerative colitis by attenuating inflammation and oxidative stress and enhancing intestinal barrier function in vivo and …

Y Wang, J Zhang, B Zhang, M Lu, J Ma, Z Liu… - Journal of …, 2023 - Elsevier
Abstract Ethnopharmacological relevance Modified Gegen Qinlian decoction (MGQD),
which was first documented in Treatise on Febrile Disease, is recognized as a classic …

[HTML][HTML] Pathological mechanism and targeted drugs of ulcerative colitis: A review

M Guo, X Wang - Medicine, 2023 - journals.lww.com
Ulcerative colitis (UC) is a chronic inflammatory disease of the colon with abdominal pain,
diarrhea, and mucopurulent stools as the main symptoms. Its incidence is increasing …

Thiol-functionalized cellulose-grafted copper oxide nanoparticles for the therapy of experimental colitis in Swiss albino mice

RK Mishra, A Selim, V Gowri, A Ahmad… - ACS Biomaterials …, 2022 - ACS Publications
Ulcerative colitis (UC) is a chronic inflammatory disease, which deleteriously affects the
lower end of the gastrointestinal tract, ie, the colon and the rectum. UC affects colonic …